Exhibiton Event
Jeisys Medical Commands Strong Presence at ‘RADLA 2026,’ Expanding Clinician Engagement Across the Latin American Market
BUENOS AIRES, Argentina — Jeisys Medical Inc., a prominent global manufacturer of energy-based medical aesthetic devices, announced the highly successful conclusion of its exhibition at 'RADLA 2026' (Reunión Anual de Dermatólogos Latinoamericanos), held from May 20 to 23 at the Centro de Convenciones Buenos Aires in Argentina, marking a major milestone in its commercial expansion across Latin America.
Celebrating its 43rd anniversary this year, RADLA stands as the most prestigious and authoritative dermatological and aesthetic congress in the Latin American region. The annual event serves as a premier international hub where leading global dermatologists, clinical experts, and industry stakeholders convene to share breakthrough clinical research, advanced technological paradigms, and evolving treatment trends.
At this year's congress, Jeisys Medical captured the centerpiece of the exhibition floor by operating three expansive corporate booths. The company showcased its heavy-hitting, energy-based portfolio, including ‘DENSITY’ (high-frequency RF), ‘POTENZA’ (microneedle RF), ‘LinearZ’ (advanced HIFU), ‘Edge ONE’ (CO2 laser), and ‘CelleV’ (premium IPL system), officially accelerating its brand-driven commercial launch in the South American sector.
A key highlight of the event was a series of high-level academic symposia led by five prominent Key Opinion Leaders (KOLs) representing Mexico, Brazil, and Peru. These medical experts presented compelling clinical data, scientific research papers, and localized protocols involving Jeisys' proprietary devices, sparking intense clinical dialogue among international physicians.
In tandem with the academic sessions, Jeisys Medical collaborated closely with its Brazilian subsidiary and distributors from seven major Latin American nations. This synchronized regional approach allowed the company to significantly fortify its institutional networks with local clinicians, unlock cross-border strategic alliances, and aggressively secure high-quality global sales leads.
"Our prominent participation in RADLA 2026 provided an invaluable platform to elevate our clinical exchange with Latin American practitioners and fundamentally solidify Jeisys Medical's premium brand equity on a global scale," said an official spokesperson for Jeisys Medical. "Moving forward, we will continuously deepen our synergy with regional partners to aggressively expand our commercial touchpoints across the South American continent."
Celebrating its 43rd anniversary this year, RADLA stands as the most prestigious and authoritative dermatological and aesthetic congress in the Latin American region. The annual event serves as a premier international hub where leading global dermatologists, clinical experts, and industry stakeholders convene to share breakthrough clinical research, advanced technological paradigms, and evolving treatment trends.
At this year's congress, Jeisys Medical captured the centerpiece of the exhibition floor by operating three expansive corporate booths. The company showcased its heavy-hitting, energy-based portfolio, including ‘DENSITY’ (high-frequency RF), ‘POTENZA’ (microneedle RF), ‘LinearZ’ (advanced HIFU), ‘Edge ONE’ (CO2 laser), and ‘CelleV’ (premium IPL system), officially accelerating its brand-driven commercial launch in the South American sector.
A key highlight of the event was a series of high-level academic symposia led by five prominent Key Opinion Leaders (KOLs) representing Mexico, Brazil, and Peru. These medical experts presented compelling clinical data, scientific research papers, and localized protocols involving Jeisys' proprietary devices, sparking intense clinical dialogue among international physicians.
In tandem with the academic sessions, Jeisys Medical collaborated closely with its Brazilian subsidiary and distributors from seven major Latin American nations. This synchronized regional approach allowed the company to significantly fortify its institutional networks with local clinicians, unlock cross-border strategic alliances, and aggressively secure high-quality global sales leads.
"Our prominent participation in RADLA 2026 provided an invaluable platform to elevate our clinical exchange with Latin American practitioners and fundamentally solidify Jeisys Medical's premium brand equity on a global scale," said an official spokesperson for Jeisys Medical. "Moving forward, we will continuously deepen our synergy with regional partners to aggressively expand our commercial touchpoints across the South American continent."